Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction

Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction

OBJECTIVES: Acute ST-elevation myocardial infarction is associated with ventricular dysfunction due to ischemia-induced progressive myocardial damage. The decrease in ventricular compliance causes left atrial dilatation and stretching of the atrial myocardium, which are the main stimuli for the secr...

Full description

Bibliographic Details
Main Authors:	Ahmet Bacaksiz, Mehmet Akif Vatankulu, Mehmet Kayrak, Hasan Huseyin Telli, Selim S. Ayhan, Osman Sonmez, Ayse Alp, Sadik Buyukbas
Format:	Article
Language:	English
Published:	Elsevier España 2013-07-01
Series:	Clinics
Subjects:	Myocardial Infarction Atrial Natriuretic Peptide Heart Atria
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000700997&lng=en&tlng=en

Similar Items

Mr-proADM and MR-proANP levels in patients with acute pulmonary embolism
by: Öner Önsel, et al.
Published: (2020-01-01)

The prognostic role of the echocardiographic tricuspid annular plane systolic excursion/systolic pulmonary arterial pressure (TAPSE/sPAP) ratio and its relationship with NT-proANP plasma level in systemic sclerosis
by: Maria Chiara Grimaldi, et al.
Published: (2023-01-01)

Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission
by: Emanuele Varaldo, et al.
Published: (2024-03-01)

Dataset of the associations of aldosterone to renin ratio with MR-proANP and MR-proADM
by: Cornelia Then, et al.
Published: (2016-09-01)

Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation
by: Timm Seewöster, et al.
Published: (2018-10-01)

Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of Nt-proANP.
by: Jonas Dahlberg, et al.
Published: (2007-05-01)

The diagnostic significance of NT-proBNP and troponin I in emergency department patients presenting with palpitations
by: TarÄ±k Ocak, et al.
Published: (2013-04-01)

Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
by: Michael Behnes, et al.
Published: (2017-08-01)

Short‐Term Influence of Radiofrequency Ablation on NT‐proBNP, MR‐proANP, Copeptin, and MR‐proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study
by: Emmanouil Charitakis, et al.
Published: (2016-09-01)

The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01)

Níveis NT-Pro-BNP e resposta ao exercício em pacientes com fluxo lento coronariano
by: Mustafa Yurtdaş, et al.

Oryeongsan (Wulingsan) ameliorates impaired ANP secretion of atria from spontaneously hypertensive rats
by: Hye Yoom Kim, et al.
Published: (2022-02-01)

Relationship between serum N-terminal Pro Brain Natriuretic Peptide (NT-Pro BNP) level and the severity of coronary artery involvements
by: Venous Shahabi, et al.
Published: (2011-01-01)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
by: Zakaria Almuwaqqat, et al.
Published: (2019-10-01)

Níveis NT-Pro-BNP e resposta ao exercício em pacientes com fluxo lento coronariano NT-Pro-BNP levels and their response to exercise in patients with slow coronary flow
by: Mustafa Yurtda&#351;, et al.
Published: (2012-01-01)

FTIR Analysis of Renal Tissue for the Assessment of Hypertensive Organ Damage and proANP<sub>31–67</sub> Treatment
by: Leonardo Pioppi, et al.
Published: (2023-03-01)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)

Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease
by: J.A. Moolman, et al.
Published: (2017-04-01)

Effects of Breed, Exercise, and a Two-Month Training Period on NT-proBNP-Levels in Athletic Dogs
by: Frane Ivasovic, et al.
Published: (2022-12-01)

Can NT-proBNP Levels Be an Early Biomarker of Reduced Left Ventricular Ejection Fraction in Preterm Infants?
by: Ya-Lan Lin, et al.
Published: (2022-07-01)

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction
by: Jesper Jensen, et al.
Published: (2020-10-01)

Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study.
by: Karl Frontzek, et al.
Published: (2014-01-01)

РОЛЬ МОЗКОВОГО НАТРІЙУРЕТИЧНОГО ПЕПТИДУ (BNP) ТА NT-PRO-МОЗКОВОГО НАТРІЙУРЕТИЧНОГО ПЕПТИДУ (NT-PRO-BNP) В ДІАГНОСТИЦІ СЕРЦЕВОЇ НЕДОСТАТНОСТІ У ПАЦІЄНТІВ З ХРОНІЧНОЮ ХВОРОБОЮ НИРОК V СТАДІЇ
by: M. Kolesnyk, et al.
Published: (2017-12-01)

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Inflammatory Myofibroblastic Tumor Invading the Left Atrium: Report of A Rare Case
by: Hikmet Sahratov, et al.
Published: (2018-02-01)

Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?
by: Tuba Cimilli Ozturk, et al.
Published: (2011-01-01)

Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
by: Reza Mohebi, et al.
Published: (2023-10-01)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
by: Lidia Staszewsky, et al.
Published: (2021-11-01)

NT-proBNP: A Biochemical Marker of Maternal Complications in Pre-eclampsia
by: Supriya Kumari, et al.
Published: (2017-11-01)

NT‐proBNP and All‐Cause and Cardiovascular Mortality in US Adults: A Prospective Cohort Study
by: Justin B. Echouffo‐Tcheugui, et al.
Published: (2023-06-01)

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
by: Henrik Rudolf, et al.
Published: (2020-08-01)

Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
by: Annette Masuch, et al.
Published: (2018-08-01)

The combined role of NT-proBNP and LV-GLS in the detection of early subtle chemotherapy-induced cardiotoxicity in breast cancer female patients
by: Laila Sulaiman, et al.
Published: (2021-03-01)

ASA Status, <i>NPPA/NPPB</i> Haplotype and Coronary Artery Disease Have an Impact on BNP/NT-proBNP Plasma Levels
by: Markus Hahn, et al.
Published: (2022-02-01)

The change in NT-pro-BNP and post-PTMC echocardiography parameters in patients with mitral stenosis. A pilot study
by: Safi Morteza, et al.
Published: (2017-06-01)

Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
by: Leonard Chiu, et al.
Published: (2024-04-01)

Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction
by: Adrish M, et al.
Published: (2017-04-01)

The relationship between serum NT-pro BNP and the severity of the COPD exacerbation
by: Farnoosh Ebrahimzadeh, et al.
Published: (2018-06-01)

Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second‐Generation Quantitative and Point‐of‐Care NT‐proBNP Measurements
by: M.J. Hezzell, et al.
Published: (2016-03-01)

Original paper<br>Weight reduction decreases NT-proBNP levels in obsese coronary patients with chronic diastolic heart failure
by: Giuseppe Cocco, et al.
Published: (2007-06-01)